Latvia's Grindeks to make Mildronate in Russia
This article was originally published in Scrip
Executive Summary
Latvia’s largest pharmaceutical manufacturer Grindeks has outsourced the injection form of its proprietary cardiovascular Mildronate to Soteks, a Russian drug maker. The company said that the manufacturing of this product at Sanitasin Lithuania and Jelfain Poland will continue.